Illustration: Sarah Grillo/Axios
Histopathology software company PictorLabs raised a $30 million Series B led by Insight Partners, CEO Yair Rivenson tells Axios exclusively.
Why it matters: Traditional histological staining methods — which are used to make tissue sample structures visible — are resource- and labor-intensive.